Detalhe da pesquisa
1.
Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study.
Br J Haematol
; 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38685596
2.
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - A study from the Danish Lymphoma Registry.
Br J Haematol
; 198(1): 50-61, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35396711
3.
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Lancet
; 393(10168): 229-240, 2019 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-30522922
4.
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.
Blood Adv
; 8(2): 407-415, 2024 01 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38113470
5.
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.
Lancet Haematol
; 2024 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38889737
6.
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study.
EClinicalMedicine
; 62: 102131, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37599908
7.
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2.
Blood Adv
; 6(19): 5550-5555, 2022 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35470385
8.
The Danish National Lymphoma Registry: Coverage and Data Quality.
PLoS One
; 11(6): e0157999, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27336800
9.
[Congenital hydrocephalus--prevalence and prognosis. Mortality and morbidity in a population-based study]. / Medfødt hydrocephalus--forekomst og prognose. Mortalitet og morbiditet i en populationsbaseret opgørelse.
Ugeskr Laeger
; 165(5): 466-9, 2003 Jan 27.
Artigo
Dinamarquês
| MEDLINE | ID: mdl-12599846
10.
Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.
Leuk Lymphoma
; 55(4): 911-9, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23915193
11.
Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas.
Leuk Lymphoma
; 60(6): 1580-1583, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30424711
12.
The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders.
Br J Haematol
; 136(5): 745-51, 2007 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17313377
13.
[New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene]. / Nye molekylaere markører ved de kroniske myeloproliferative sygdomme. I. Polycythaemia rubra vera-1-genet.
Ugeskr Laeger
; 168(39): 3295-9, 2006 Sep 25.
Artigo
Dinamarquês
| MEDLINE | ID: mdl-17032591
14.
[New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation]. / Nye molekylaere markører ved de kroniske myeloproliferative sygdomme. II. Janus tyrosinkinase 2-mutationen.
Ugeskr Laeger
; 168(39): 3299-303, 2006 Sep 25.
Artigo
Dinamarquês
| MEDLINE | ID: mdl-17032592